Repository logo
 
Publication

Major Pulmonary Surgery in Patients with Compromised Lung Function

dc.contributor.authorGonçalves Pereira, R
dc.contributor.authorBranco, J
dc.contributor.authorNarciso Rocha, F
dc.contributor.authorFigueiredo, C
dc.contributor.authorCosta, AR
dc.contributor.authorSantos Silva, J
dc.contributor.authorEurico Reis, J
dc.contributor.authorCalvinho, P
dc.date.accessioned2023-02-22T15:14:25Z
dc.date.available2023-02-22T15:14:25Z
dc.date.issued2021-11
dc.description.abstractIntroduction: The risk stratification of lung resection is fundamentally based on the results of pulmonary function tests. In patients considered to be at risk, major surgery is generally denied, opting for potentially less curative therapies. Objective: To evaluate the postoperative outcomes of major lung surgery in a group of patients deemed high risk. Methods: We performed a retrospective review of clinical records of all patients submitted to lobectomy, bilobectomy or pneumonectomy in a 3-year period in a reference Thoracic Surgery Unit. The patients were then divided in two groups: group A composed of patients with normal preoperative pulmonary function and group B which included patients with impaired lung function, defined as FEV1 and/or DLCO ≤60%. Results: A total of 234 patients were included, 181 (77.4%) in group A and 53 (22.6%) in group B. In group B, patients had more smoking habits, were more often associated with chronic obstructive pulmonary disease and were also more frequently submitted to thoracotomy. When surgery was motivated by primary lung cancer this group had a more advanced clinical stage of the disease. In the postoperative period, these patients had longer hospital stay, longer chest drainage time and greater need for oxygen therapy at home, however, no statistically significant difference was noted in morbidity or mortality. Conclusions: Major thoracic surgery can be safely performed in selected patients considered to be high risk for resection by pulmonary function tests. A potentially curative surgery should not be denied based on respiratory function tests alone.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationPort J Card Thorac Vasc Surg . 2021 Nov 7;28(3):25-32.pt_PT
dc.identifier.doi10.48729/pjctvs.191.pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/4419
dc.language.isoengpt_PT
dc.publisherSociedade Portuguesa de Cirurgia Cardio-Torácica e Vascularpt_PT
dc.subjectHSM CCTpt_PT
dc.subjectHumanspt_PT
dc.subjectLung / surgerypt_PT
dc.subjectLung Diseases* / surgerypt_PT
dc.subjectPneumonectomy / adverse effectspt_PT
dc.subjectPostoperative Complications* / epidemiologypt_PT
dc.subjectRespiratory Function Testspt_PT
dc.titleMajor Pulmonary Surgery in Patients with Compromised Lung Functionpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage32pt_PT
oaire.citation.startPage25pt_PT
oaire.citation.titlePortuguese Journal of Cardiac Thoracic and Vascular Surgerypt_PT
oaire.citation.volume28pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RPCCV 2021 25-32.pdf
Size:
233.59 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections